Testing effectiveness (Phase 2)UnknownNCT03946917What this trial is testingJS001 Combined With Regorafenib in Patients With Advanced Colorectal CancerWho this might be right forColorectal Cancer Sun Yat-sen University 44
Early research (Phase 1)Ended earlyNCT06877533What this trial is testingA First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid TumorsWho this might be right forSelected Advanced Solid Tumors iTeos Belgium SA 3
Testing effectiveness (Phase 2)Study completedNCT03989336What this trial is testingThe Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian CancerWho this might be right forOvarian Cancer Chinese PLA General Hospital 84
Large-scale testing (Phase 3)Looking for participantsNCT03907826What this trial is testingPD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma PatientsWho this might be right forRecurrent Nasopharyngeal Carcinoma Sun Yat-sen University 212
Not applicableUnknownNCT06095934What this trial is testingEfficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI TreatmentWho this might be right forNSCLCEGFR Gene Mutation The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 20
Large-scale testing (Phase 3)Study completedNCT04063163What this trial is testingA Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLCWho this might be right forExtensive Stage Small Cell Lung Cancer Shanghai Henlius Biotech 585
Testing effectiveness (Phase 2)Looking for participantsNCT03810339What this trial is testingToripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid TumorsWho this might be right forSolid TumorAdvanced Cancer Sun Yat-sen University 35
Testing effectiveness (Phase 2)WithdrawnNCT05290194What this trial is testingRadiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal CarcinomaWho this might be right forRadiotherapyPD-1 InhibitorCapecitabine+1 more Fifth Affiliated Hospital, Sun Yat-Sen University
Testing effectiveness (Phase 2)Study completedNCT02694822What this trial is testingAGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent TherapyWho this might be right forAdvanced Solid CancersAdvanced Solid Cancers Refractory to PD-1 and PD-L1 Therapies Agenus Inc. 89
Large-scale testing (Phase 3)Looking for participantsNCT04778956What this trial is testingToripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal CarcinomaPD-1Surgery Sun Yat-sen University 218
Testing effectiveness (Phase 2)UnknownNCT04026269What this trial is testingClinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP RegimenWho this might be right forHodgkin Lymphoma Han weidong 30
Early research (Phase 1)Active Not RecruitingNCT05789069What this trial is testingHFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsWho this might be right forRenal Cell CarcinomaMelanomaNon Small Cell Lung Cancer+2 more HiFiBiO Therapeutics 83
Testing effectiveness (Phase 2)Looking for participantsNCT06865339What this trial is testingThoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung CancerWho this might be right forNSCLCLocally Advanced Montefiore Medical Center 76
Early research (Phase 1)Looking for participantsNCT06896422What this trial is testingRandomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLCWho this might be right forNon-Small Cell Lung CancerChemotherapyPD1 Antibody+1 more The First Affiliated Hospital of Zhengzhou University 80
Testing effectiveness (Phase 2)UnknownNCT04174781What this trial is testingAnti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCCWho this might be right forHepatocellular Carcinoma Zhejiang University 61
Testing effectiveness (Phase 2)Study completedNCT03394287What this trial is testingA Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBCWho this might be right forBreast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Testing effectiveness (Phase 2)UnknownNCT04052152What this trial is testingAnlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC)Who this might be right forAdvanced Hepatocellular Carcinoma The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05769816What this trial is testingA Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)Who this might be right forChronic Hepatitis bAnti-PD-1 Antibody The Second Affiliated Hospital of Chongqing Medical University 120
Testing effectiveness (Phase 2)Study completedNCT03132636What this trial is testingPD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor TherapyWho this might be right forCarcinoma, Basal Cell Regeneron Pharmaceuticals 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT06576921What this trial is testingEfficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric JunctionWho this might be right forStomach NeoplasmsImmune Checkpoint Inhibitors Xijing Hospital 116